# BioMarin Pharmaceutical, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

> Inspection records and compliance data for BioMarin Pharmaceutical, Inc. in Novato, California. Access full analysis and detailed observations.

---

## Details

- Name: BioMarin Pharmaceutical, Inc.
- FEI Number: 3004079983
- City: Novato
- State: California
- Country Name: United States
- Address Line 1: 46 Galli Dr
- Zip Code: 94949

## Related Documents

- [483 - BioMarin Pharmaceutical, Inc. - Unknown Date](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/738d34c2-9e7c-4315-95b4-b0dcc2e07b20) — source: FDA, date: Invalid Date
- [FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - 2025-03-26](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/82d2a0af-f568-4ba0-b631-24e73e69b55a) — source: FDA, date: March 26, 2025
- [FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - 2025-03-26](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/4cd4613e-939f-4c47-ab0f-730de2e9c32b) — classification: No Action Indicated (NAI), source: FDA, date: March 26, 2025
- [483 - BioMarin Pharmaceutical, Inc. - 2024-08-19](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/59238adc-e27c-4c98-954a-e756c73ea1ea) — source: FDA, date: August 19, 2024
- [FDA Inspection 1251795 - BioMarin Pharmaceutical, Inc. - 2024-08-19](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/e8b2b049-ebee-414e-99e1-b3ba421792a2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2024
- [483 - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/1e97f714-134a-473e-8ca8-bbb33d74dfd1) — source: FDA, date: April 2, 2021
- [EIR - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/1d79f65a-b3d4-47d3-b05d-e2df9c3252df) — source: FDA, date: April 2, 2021
- [483 - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/68119bf5-5042-4336-9c03-7fde3f113010) — source: FDA, date: April 2, 2021
- [EIR - BioMarin Pharmaceutical, Inc. - 2018-11-09](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/d68114e4-98af-4ad9-9a84-ee2c914e8a3a) — source: FDA, date: November 9, 2018
- [EIR - BioMarin Pharmaceutical, Inc. - 2017-12-14](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/ed544e08-f6aa-4d9c-afdc-7ea7c99813dd) — source: FDA, date: December 14, 2017
- [FDA Inspection 1041169 - BioMarin Pharmaceutical, Inc. - 2017-12-14](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/294a4562-e09d-41ef-b5da-6e26860ddf6d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2017
- [FDA Inspection 991276 - BioMarin Pharmaceutical, Inc. - 2016-11-04](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/04c426b2-4a4c-42cc-893a-c7f7b303b7d2) — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2016
- [483 - BioMarin Pharmaceutical, Inc. - 2014-04-17](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/cae106c6-e26b-4552-bd9f-10fa67375f17) — source: FDA, date: April 17, 2014
- [FDA Inspection 878935 - BioMarin Pharmaceutical, Inc. - 2014-04-17](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/321d151b-0d6a-4a07-8f37-0b8da6e570b6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2014
- [FDA Inspection 852996 - BioMarin Pharmaceutical, Inc. - 2013-09-24](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/7ab805bb-a1a9-4fa4-af11-6f47da4be11b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2013
- [FDA Inspection 854766 - BioMarin Pharmaceutical, Inc. - 2013-06-28](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/29eaa903-9ac8-4525-a2ca-5ffa798d4ac0) — classification: No Action Indicated (NAI), source: FDA, date: June 28, 2013
- [FDA Inspection 751754 - BioMarin Pharmaceutical, Inc. - 2011-11-03](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/f79ac3f2-8a3b-4174-b32e-bbc9d76a7902) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2011
- [FDA Inspection 671734 - BioMarin Pharmaceutical, Inc. - 2010-07-15](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/8cfeaed2-5bc5-4f4d-ba7a-89e088093fb0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2010

## Related Companies

- [Nanjing Cuccess Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nanjing-cuccess-pharmaceutical-co-ltd/34bd5da4-2efe-4abc-9322-6847e76f7dda)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92)
- [Zoetis LLC](https://www.keypedia.com/companies/zoetis-llc/1ea95bb9-fb5b-458d-bfff-ca0195c13aa6)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Suzhou Union Biopharm Co., Ltd.](https://www.keypedia.com/companies/suzhou-union-biopharm-co-ltd/5d9c9c07-1afc-44da-b4ff-872317d01143)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [ALK-Abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/b626f86d-b379-45aa-96d2-0661e9d1c981)
- [Cipla, Ltd.](https://www.keypedia.com/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)

## Related Officers

- [Anh M. Lac](https://www.keypedia.com/people/anh-m-lac/20a897c2-ad8c-4bea-8060-34ba80d64d1e)
- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [company_representative](https://www.keypedia.com/people/amy-kenner/058a4567-e4d3-4c7c-942c-06d6b0f9fe61)
- [company_representative](https://www.keypedia.com/people/victoria-sluzky/12846ad6-4449-434b-af7b-91c703b6a392)
- [issuing_officer](https://www.keypedia.com/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)
- [recipient](https://www.keypedia.com/people/janet-hsu/31b3ec67-81e8-471e-b2f6-ed6af6a87cbd)